In silico study of medicinal plants with cyclodextrin inclusion complex as the potential inhibitors against SARS-CoV-2 main protease (Mpro) and spike (S) receptor
| Autor: | Bagas Adji Prabowo, Casilda Aulia Rakhmadina, Doni Dermawan |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
medicine.medical_treatment In silico Computer applications to medicine. Medical informatics R858-859.7 Health Informatics Pharmacology medicine.disease_cause Article 03 medical and health sciences 0302 clinical medicine Medicinal plants medicine Cyclodextrin Coronavirus ADME chemistry.chemical_classification Protease SARS-CoV-2 Chemistry Spike receptor Ligand (biochemistry) 030104 developmental biology Main protease 030220 oncology & carcinogenesis Drug delivery Pharmacophore |
| Zdroj: | Informatics in Medicine Unlocked Informatics in Medicine Unlocked, Vol 25, Iss, Pp 100645-(2021) |
| ISSN: | 2352-9148 |
| Popis: | The current outbreak of novel coronavirus disease (COVID-19) causes an alarming number of deaths in 221 countries around the world. Nowadays, there is no specific and effective drug regimen for curing COVID-19. Since the COVID-19 pandemic, several medicinal plants with promising results in the previous SARS-CoV could be used to treat SARS-CoV-2 infected patients. This work assesses proven medicinal plants as potential inhibitors against SARS-CoV-2 main protease (Mpro) and spike (S) receptors by employing in silico methods. Molecular docking studies and 3D structure-based pharmacophore modeling were performed to identify the molecular interactions of potential active molecules with the Mpro and (S) receptor of SARS-CoV-2. The drug-likeness and ADME properties were also predicted to support the drug-like nature of the selected active molecules. The results indicated that the most favorable ligand was Terrestriamide with (ΔG: ─8.70 kcal/mol; Ki: 0.417 μM) and (ΔG: ─7.02 kcal/mol; Ki: 7.21 μM) for Mpro and (S) receptor, respectively. Terrestriamide is also supported with a high drug-likeness value and appropriate ADME profile. Furthermore, to improve drug delivery, the cyclodextrin inclusion complex was calculated based on semi-empirical quantum mechanical methods. Terrestriamide/γ−cyclodextrin is the most favorable pathway of inclusion complex formation and could be used to treat COVID-19. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|